Evidence map›Paper›PMID 40668288›Full record

ArticleClinical rheumatology2025

Clinical presentation of children with lupus nephritis from a low- and middle-income country (LMIC): an initial report from the Indian pSLE Nephritis Registry.

Sanjukta Poddar, Deblina Dasgupta, Subal Pradhan, Sangeetha Perungo, Mahesh Janarthanan, Kinnari Vala, Priya Pais, Susan Uthup, Jyoti Singhal, Suparna Guha and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sanjukta PoddarDivision of Pediatric Nephrology, Institute of Child Health, Kolkata, India.
Deblina DasguptaDivision of Pediatric Nephrology, Institute of Child Health, Kolkata, India.
Subal PradhanDivision of Pediatric Nephrology, Sardar Vallabhbhai Patel Post Graduate Institute of Pediatrics, Cuttack, India.
Sangeetha PerungoPediatric Nephrology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Mahesh JanarthananDepartment of Clinical Immunology & Rheumatology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Kinnari ValaDepartment of Pediatric Nephrology, Smt. GR Doshi and Smt. KM Mehta Institute of Kidney Diseases and Research Center, Gujarat University of Transplantation Sciences, Ahmedabad, India.
Priya PaisDepartment of Pediatric Nephrology, St John's Medical College, St John's National Academy of Health Sciences, Bengaluru, India.
Susan UthupDepartment of Pediatric Nephrology, Government Medical College, Thiruvananthapuram, India.
Jyoti SinghalPediatric Nephrology Service, Renal Unit, King Edward Memorial Hospital, Pune, India.
Suparna GuhaDepartment of Pediatrics, Vivekananda Institute of Medical Sciences, Kolkata, India.
Sumantra RautDepartment of Nephrology, North Bengal Medical College and Hospital, Siliguri, India.
Shakil AkhtarDivision of Pediatric Nephrology, Institute of Child Health, Kolkata, India.
Jigna BathiaPediatric Rheumatology Unit, Institute of Child Health, Kolkata, India.
Suma BalanDepartment of Rheumatology and Clinical Immunology, Amrita Institute of Medical Sciences, Cochin, India.
Priyankar PalPediatric Rheumatology Unit, Institute of Child Health, Kolkata, India.
Rajiv SinhaDivision of Pediatric Nephrology, Institute of Child Health, Kolkata, India. rajivsinha_in@yahoo.com.ORCID http://orcid.org/0000-0003-4525-092X
On behalf, of the Indian pSLE Nephritis consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLimited prospective data exist on pediatric LN (pLN) from low- and middle-income countries (LMIC), where ethnicity, socioeconomic factors, and healthcare access are likely to differ from high-income countries.

methodsThe Indian Pediatric Lupus Nephritis registry has been running since 2020 across multiple centers in India. Children (≤ 18 years) diagnosed with lupus (as per 2012 SLICC criteria), presenting with nephritis, and confirmed by kidney biopsy are being prospectively enrolled. Clinical data, laboratory investigations, kidney biopsy results, and treatment responses have been documented prospectively. The current report documents their initial presentation.

resultsA total of 154 children (75% female, median age 12 years-IQR 10-14 years) with biopsy-proven LN were enrolled by July 2024. Nearly two-thirds had LN at SLE diagnosis, and the rest developed within a maximum of 5 years of initial presentation. Common manifestations at presentation included edema (75%), hypertension (54%), and proteinuria (98%), of which 68% presented with nephrotic-range proteinuria. Acute kidney injury (AKI) was observed in 43%, with 20% in stage 3. Ninety-four percent of our cohort had low complements (C3, C4, or both), and 96% were ANA-positive. Class IV LN was the most common (45%) histopathological type and had significantly lower estimated glomerular filtration rate in comparison to Class V LN.

conclusionKidneys are often involved in the initial presentation of childhood lupus, and the majority have proliferative nephropathy leading to AKI, hypertension, and significant proteinuria. Children enrolled in the registry are under active follow-up to assess the renal responses which will help optimize the management of pLN in LMICs. Key Points •It is a well-known fact that kidney involvement is more common in pediatric lupus and is among one of the most important long-term prognostic factors. •There is scarcity of data on pediatric lupus nephritis (pLN) particularly from low- and middle-income countries (LMIC), and even among them, the majority of the studies are retrospective and limited by a small cohort size. •Through this prospective registry from a LMIC, we demonstrated that 2/3rd of children with lupus have kidney involvement at presentation and almost all (90%) develop LN within 2 years of the diagnosis of lupus. •Acute kidney injury (AKI) is known to increase mortality/morbidity risks independently. Many of the previous studies have under-reported AKI in pLN, probably because the data was collected retrospectively. On the other hand, we found AKI to be very common and to be present in about half of the cases at presentation.

Indexed as

Lupus NephritisAcute Kidney InjuryAdolescentBiopsyChildDeveloping CountriesFemaleHumansIndiaKidneyMaleProspective StudiesRegistriesAcute kidney injury (AKI)Anti-nuclear antibody (ANA)EdemaEstimated glomerular filtration rate (eGFR)HematuriaHistopathologyHypertensionKidney biopsyKidney replacement therapy (KRT)Lupus nephritis (LN)Nephrotic syndromeProteinuriaPSLE Nephritis RegistrySystemic lupus erythematosus (SLE)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.